NewsWatch: Goldman cuts U.S. growth forecast after Sen. Joe Manchin rejects Biden’s $2 trillion spending plan
Goldman Sachs says President Joe Biden’s signature $2 trillion spending plan had already looked like a close call.
Biogen Inc. undefined said Monday it will reduce the price of its Alzheimer’s drug aduhelm by 50% starting Jan. 1 in an effort to get it to more pa…
Get news sent directly to your inbox
Get breaking news and incisive analysis sent to your inbox. Choose from a number of free newsletter options at MarketWatch, including Need to Know, which provides a guide to the trading day.